Category Archives: News

The American Cancer Society Gives Tips on Healthy Living to Prevent Cancer

The American Cancer Society Gives Tips on Healthy Living to Prevent Cancer
The American Cancer Society Gives Tips on Healthy Living to Prevent Cancer

How proactive are you about your health? According to the American Cancer Society, the healthy living tips recommended for patients undergoing cancer treatment can also reduce the risk of developing cancer in the first place.

Good Nutrition and Physical Activity Can Reduce Cancer Risk

According to the World Cancer Research Fund, approximately 20 percent of cancer cases in the United States are connected to poor health habits, including obesity, excessive alcohol consumption, physical inactivity and lack of nutrition.

Here’s a look at how you can start today to reduce your personal cancer risk.

1. Maintain a Healthy Weight

Excess weight puts hormones such as estrogen and insulin into overdrive, which can promote development of tumors. In addition to reducing cancer risk, maintaining a healthy weight prevents or controls diabetes, cardiovascular disease and other issues.

2. Be Physically Active

Exercise involves physical activity performed at a moderate or vigorous intensity. This can include gardening, walking and biking as well as more traditional forms such as sports and weight lifting. Aim for at least 150 minutes of moderate activity or 75 minutes of vigorous activity every week.

3. Follow a Nutritious Diet

– Avoid processed foods.

– Eat at least 2-1/2 cups of fruits and vegetables daily.

– Choose foods that are low in fat, sugar and calories.

– Cut back or eliminate refined carbohydrates in favor of whole-grain products.

– Eat smaller portions.

– Limit your intake of alcohol.

Integrative Cancer Treatment at Issels®

At Issels®, our personally tailored cancer treatment programs combine a number of complementary elements, including nutritional immunotherapy. Contact us to learn why we are the leader in non-toxic, state-of-the-art immunotherapy cancer treatment.

Some Cancers Cloak Themselves from the Immune System’s Discovery

Some Cancers Cloak Themselves from the Immune System's Discovery
Some Cancers Cloak Themselves from the Immune System’s Discovery

Immunotherapy cancer treatment is designed to aid the body’s immune system in recognizing and attacking tumor cells. Scientists are finally uncovering clues as to how cancer cells are able to evade detection by the body’s natural defenses.

How Cancer Blocks the Immune System

The first steps were taken in 2009 by a team headed up by Dr. Irving Weissman, director of Stanford’s Institute for Stem Cell Biology and Regenerative Medicine. Their research discovered that some cancer cells are able to emit a “don’t eat me” signal.

High levels of CD47, a transmembrane protein, are found on the surface of more aggressive cancer cells. CD47 then binds with another protein called SIRPalpha on the surface of macrophages, a type of white blood cell, inhibiting their ability to attack cancer cells.

In 2017, Dr. Weissman’s team published the results of a recent study that identified another protein that interferes with macrophage activity. When MHC class 1 binds with a protein known as LILRB1, it’s resistant to an antibody that has been used successfully to counteract CD47 in tests on mice with cancer.

Applications for Immunotherapy Cancer Treatment

Cancer research is complicated by the fact that different types have different “fingerprints.” The studies conducted by Dr. Weissman’s team are helping scientists learn more about strategies to “outwit” cancer cells and their ability to avoid detection.

Issels®: Pioneering Immunotherapy Cancer Treatment

Our founder, Dr. Josef Issels, was ahead of his time in focusing on the immune system as the key to defeating advanced cancer. Contact us to learn more about how we are continuing his legacy of helping patients achieve long-term remission.

Molecularly Targeted Therapy Emerges As Another Possible Cancer Treatment

Molecularly Targeted Therapy Emerges As Another Possible Cancer Treatment
Molecularly Targeted Therapy Emerges As Another Possible Cancer Treatment

The problem with traditional cancer treatments is that they attack healthy cells along with diseased cells, which results in serious side effects such as fatigue and hair loss. Doctors are encouraged by the success of a new cancer treatment that zeroes in on the cancer cells.

The “Next Revolution in Cancer Therapy”

Molecularly targeted therapy is being hailed as the next big step in cancer treatment. These new drugs are designed at the molecular level to attack the diseased cells of a specific type of cancer. In addition, they can identify specific molecules that are part of specific cancers.

The drugs are created by a process that is the reverse of how most cancer drugs are developed. Scientists identify an abnormal molecule that’s unique to a particular type of cancer, then design a drug that shuts down its activity.

Gleevec: Paving the Way

Novartis Pharmaceuticals has developed Gleevec, also known as STI571, which is leading the way for molecularly targeted therapy. Gleevec is used for chronic myeloid leukemia, or CML, which is a rare form of the disease characterized by excessive production of white blood cells.

Researchers discovered that Gleevec is also effective against GIST, a rare gastrointestinal cancer. GIST features a unique enzyme related to the original target enzyme in CML.

State-of-the-Art Cancer Treatment at Issels®

Gene-targeted therapies, including Gleevec, Tamoxifen and Avastin, are a significant part of our personalized treatment programs. Issels® also uses non-toxic immunotherapy treatments that boost the immune system’s ability to target tumor cells.

Contact us today for more information about our decades of success in helping patients achieve long-term remission.

Cancer Treatment: Foods to Avoid While in Treatment

Cancer Treatment: Foods to Avoid While in Treatment
Cancer Treatment: Foods to Avoid While in Treatment-

When you undergo cancer treatment, chances are good that side effects such as nausea and mouth sores will cause your taste buds to change. Your overall health can also be affected by the nutritional choices you make.

Many types of cancer treatments can weaken your immune system, even after they’re over. As a result, your body is vulnerable to food-borne bacteria and viruses that otherwise might not affect you.

Here are foods you should avoid during and after treatment to reduce the risk of food poisoning, even if they haven’t caused problems in the past.

Proteins

– Smoked fish

– Raw or undercooked beef and seafood, including sushi and sashimi

– Raw, unpasteurized eggs and items such as raw cookie dough that are made with raw eggs

– Undercooked eggs, including soft-boiled, over-easy and poached

– Soft cheeses made from unpasteurized milk, such as Brie, feta and goat cheese

– Deli salads made with chicken, eggs, seafood or ham

– Cold hot dogs or cold deli meat, which should always be cooked until steaming hot

– Refrigerated paté

Produce

– Fresh fruits and vegetables that have not been washed

– Unpasteurized fruit juice or cider

– Raw sprouts

If you’re uncertain about any food items, don’t take chances. Talk to your healthcare team before consuming any questionable products.

Personalized Cancer Treatment from Issels®

Our individually tailored treatment programs are designed to boost the effectiveness of your body’s immune system. In addition, our immunotherapy doesn’t have the debilitating side effects that often accompany traditional forms of cancer treatment.

Contact us for more information about our cancer vaccines and other treatments we have been successfully using for decades.

Why Many Breast Cancer Patients Stop Treatment or Only Take Partial Treatment

Why Many Breast Cancer Patients Stop Treatment or Only Take Partial Treatment
Why Many Breast Cancer Patients Stop Treatment or Only Take Partial Treatment

Many women do not trust the health care system and will often forgo radiation and drug therapy after breast cancer surgery. That is according to a survey of 2,700 breast cancer patients by researchers at Johns Hopkins University. Lead author of the survey, Lorraine Dean, said over 30 percent skip treatments that are intended to kill any cancer cells that remain after surgery.

Contact Issels® for information on how combining conventional treatments with immunotherapy cancer treatment reduces the likelihood of relapse.

Doctor-patient trust is crucial

Cancer is a devastating disease and it is understandable that patients experience feelings of helplessness. It’s not just women with breast cancer who are losing trust in doctors and the health care system, it’s the general public as well. People often feel that doctors put their own financial interest ahead of patient care. When patients feel their doctors don’t listen to them or take their concerns seriously, trust begins to erode.

For the best possible outcome, it is necessary that doctors and patients have a strong bond of trust. Patients should feel comfortable being fully honest with health care providers and the doctors should always remember that a patient’s trust in them is a vital and necessary component of proper medical care. Each person’s cancer is unique and treatment should be based on the specific needs of each patient.

Personalized cancer treatment

At Issels®, we have been practicing individualized treatment for more than 60 years. We want you to make informed decisions about your cancer treatment options. Contact us today for more information on our autologous (from the patient’s own blood) non-toxic cancer treatment protocols.

Drug Resistant Cancer Cells Appear to Share a Similar Weakness

Medical Research Has Validated that Immunotherapy Works to Fight Cancer
Medical Research Has Validated that Immunotherapy Works to Fight Cancer

Cancer researchers at UC San Francisco have discovered a common gene vulnerability in certain treatment-resistant cancers. This is yet another promising advancement that could lead to better treatment of existing cancers and a new approach to preventing cancer recurrences.

Visit Issels® for more information on how combining traditional cancer treatments with integrative immunotherapy can reduce the incidence of relapse from 13 to 50 percent.

Understanding drug-resistant cancer cells

For many years, oncologists thought the drug resistance of cancer cells evolved genetically. Doctors thought a few of the cells survived cancer treatment because they had or somehow developed gene mutations to withstand traditional treatments. These remaining cells would then lead to a recurrence of cancer.

In 2010, researchers working at the Massachusetts General Hospital Cancer Center found that some cancer cells may be able to avoid the effects of treatment without any genetic mutations. These small clumps of cells are called “persister cells” and they go into a dormant state, allowing them to survive cancer drugs. The cells awaken later and lead to new cancer growth.

Exploiting persister cell weaknesses

Matthew Hangauer, PhD led the UC San Francisco study. He said persister cancer cells have a mesenchymal-like gene expression signature and rely on the enzyme glutathione peroxidase 4 (GPX4) to survive treatment. Lab tests show that blocking GPX4 can kill the persister cells found in many different cancer types. Researchers hope to soon validate their findings with human patients.

The Issels® non-toxic cancer treatment

Our caring and knowledgeable experts have helped many patients achieve long-term remission from cancer by using personalized immunotherapy treatment protocols. Contact us for more information.